VIZIO 40-inch D-Series TV (2021, D40f-J09)
The VIZIO 40-inch D-Series offers a solid Full HD viewing experience, enhanced by Apple AirPlay and Chromecast for versatile streaming options. As a renewed model, it's a cost-effective choice for those seeking affordability, though it may not match brand-new condition standards. Overall, it’s a great option for budget-conscious buyers looking for smart features in a reliable TV.
Where to Buy
| Retailer | Price | Last seen | Buy |
|---|---|---|---|
 Amazon Sold by Hyper Microsystems | $136.99 | Mar 11, 2025, may have changed | Buy Now |
M Mercari | $159.00 | Nov 6, 2024, may have changed | Buy Now |
T TrueGether Sold by Top Rated Sellers | $199.99 | Oct 10, 2022, may have changed | Buy Now |
Prices are collected from retailer listings; each row shows the date we last saw that price.
Used & Refurbished
✨ See 2 used & refurbished prices with ShopSavvy ProGet the app →Pros
- •Full HD 1080p resolution for clear picture quality.
- •Apple AirPlay and Chromecast Built-in for easy streaming and screen mirroring.
- •Access to 150+ free streaming channels without needing extra subscriptions.
Cons
- •This is a renewed product, so it's previously used and refurbished.
- •Some users may find the build quality of renewed products less than pristine.
Bottom Line
The VIZIO 40-inch D-Series offers a solid Full HD viewing experience, enhanced by Apple AirPlay and Chromecast for versatile streaming options. As a renewed model, it's a cost-effective choice for those seeking affordability, though it may not match brand-new condition standards. Overall, it’s a great option for budget-conscious buyers looking for smart features in a reliable TV.
What Reviewers Are Saying
Professional Reviews
📚More About VIZIO 40-inch D-Series TV (2021, D40f-J09)
Discussion
ShopSavvy compares prices across thousands of retailers so you always get the best deal. Prices are collected from retailer listings, and each one shows the date we last saw it. Our expert reviews and community discussion help you make informed buying decisions.